Table 2.
Adverse events.
1st Dose | Patients, n (%) | HV, n (%) | p Value |
---|---|---|---|
Fever | 1 (4) | 1 (5) | 1 |
Pain | 20 (80) | 12 (63) | 0.308 |
Redness | 1 (4) | 0 (0) | 1 |
Swelling | 2 (8) | 2 (11) | 1 |
Headache | 4 (16) | 0 (0) | 0.122 |
Fatigue | 5 (20) | 4 (21) | 1 |
Chills | 2 (8) | 0 (0) | 0.498 |
Muscle pain | 3 (12) | 1 (5) | 0.622 |
Joint pain | 2 (8) | 0 (0) | 0.498 |
Vomiting | 1 (4) | 0 (0) | 1 |
Diarrhea | 1 (4) | 1 (5) | 1 |
2nd dose | |||
Fever | 1 (4) | 2 (11) | 0.181 |
Pain | 17 (68) | 13 (68) | 1 |
Redness | 2 (8) | 1 (5) | 1 |
Swelling | 6 (24) | 2 (11) | 0.433 |
Headache | 7 (28) | 1 (5) | 0.111 |
Fatigue | 13 (52) | 6 (32) | 0.227 |
Chills | 2 (8) | 1 (5) | 1 |
Muscle pain | 3 (12) | 1 (5) | 0.622 |
Joint pain | 1 (4) | 0 (0) | 1 |
Vomiting | 0 (0) | 0 (0) | 1 |
Diarrhea | 1 (4) | 0 (0) | 1 |
Skin rash | 1 (4) | 0 (0) | 1 |
HV, healthy volunteers.